New England Research & Management’s Edwards Lifesciences EW Stock Holding History

New England Research & Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3,780	Closed	-$316K	–	179
2021 Q1	$316K	Hold	3,780	–	–	0.17%	133
2020 Q4	$345K	Hold	3,780	–	–	0.21%	123
2020 Q3	$302K	Hold	3,780	–	–	0.22%	110
2020 Q2	$261K	Hold	3,780	–	–	0.19%	130
2020 Q1	$238K	Buy	+3,780	New	+$273K	0.2%	119
2019 Q3	–	Sell	-5,250	Closed	-$323K	–	168
2019 Q2	$323K	Buy	+5,250	New	+$317K	0.22%	131
2018 Q4	–	Sell	-13,050	Closed	-$757K	–	168
2018 Q3	$757K	Buy	+13,050	New	+$638K	0.49%	75
2017 Q4	–	Sell	-10,050	Closed	-$366K	–	158
2017 Q3	$366K	Buy	+10,050	New	+$383K	0.27%	105

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

New England Research & Management's EW Position: Q2 2021 in Review

New England Research & Management sold out of Edwards Lifesciences (EW) in Q2 2021, closing a stake of 3,780 shares — an estimated $316K sold.

New England Research & Management first reported a position in EW in Q3 2017 and held it in 8 quarters. The position peaked at $757K in Q3 2018. 1,188 funds tracked by Wall St. Rank hold EW as of Q2 2021.

New England Research & Management reported no remaining Edwards Lifesciences position as of Q2 2021 after selling out during the quarter.
New England Research & Management sold 3,780 Edwards Lifesciences shares in Q2 2021, an estimated $316K.
New England Research & Management first reported a position in Edwards Lifesciences in Q3 2017 and held it in 8 quarters.
New England Research & Management's Edwards Lifesciences position peaked at $757K in Q3 2018.
1,188 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2021.

Based on New England Research & Management's 13F filing for Q2 2021, filed 15 Jul 2021.